Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

被引：0
|
作者：
Dominic Pilon
Erik Muser
Patrick Lefebvre
Rhiannon Kamstra
Bruno Emond
Kruti Joshi
机构：
[1] Groupe d’analyse,
[2] Ltée,undefined
[3] Janssen Scientific Affairs,undefined
[4] LLC,undefined
来源：
BMC Psychiatry | / 17卷
关键词：
Oral Atypical Antipsychotics (OAA); Healthcare Resource Utilization; Mean Monthly Cost; Medical Cost Savings; Higher Pharmacy Costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
    Pilon, Dominic
    Muser, Erik
    Lefebvre, Patrick
    Kamstra, Rhiannon
    Emond, Bruno
    Joshi, Kruti
    BMC PSYCHIATRY, 2017, 17
  • [2] Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics
    Kamstra, Rhiannon
    Pilon, Dominic
    Lefebvre, Patrick
    Emond, Bruno
    Joshi, Kruti
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1377 - 1388
  • [3] ONCE-MONTHLY PALIPERIDONE PALMITATE COMPARED WITH ORAL ATYPICAL ANTIPSYCHOTIC TREATMENT IN PATIENTS WITH SCHIZOPHRENIA
    Kim, E.
    Starr, H. L.
    Bossie, C.
    Mao, Lian
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S318 - S318
  • [4] Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate
    Lin, Dee
    Pilon, Dominic
    Zhdanava, Maryia
    Joshi, Kruti
    Lafeuille, Marie-Helene
    Cote-Sergent, Aurelie
    Vermette-Laforme, Maude
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 675 - 683
  • [5] TREATMENT PATTERNS AND MEDICAID SPENDING IN COMORBID SCHIZOPHRENIA POPULATIONS: ONCE-MONTHLY PALIPERIDONE PALMITATE VS ORAL ATYPICAL ANTIPSYCHOTICS
    Kamstra, R.
    Pilon, D.
    Lefebvre, P.
    Emond, B.
    Joshi, K.
    VALUE IN HEALTH, 2018, 21 : S180 - S180
  • [6] Once-monthly paliperidone palmitate compared with oral conventional or oral atypical antipsychotic treatment in patients with schizophrenia
    Alphs, L.
    Starr, H. L.
    Mao, L.
    Bossie, C. A.
    Kim, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S524 - S525
  • [7] Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia
    Kim, Edward
    Correll, Christoph U.
    Mao, Lian
    Starr, H. Lynn
    Alphs, Larry
    CNS SPECTRUMS, 2016, 21 (06) : 466 - 477
  • [8] Health care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment
    Pesa, Jacqueline A.
    Doshi, Dilesh
    Wang, Li
    Yuce, Huseyin
    Baser, Onur
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 723 - 731
  • [9] Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
    Bruno Emond
    Kruti Joshi
    Antoine C. El Khoury
    Marie-Hélène Lafeuille
    Dominic Pilon
    Neeta Tandon
    Hela Romdhani
    Patrick Lefebvre
    PharmacoEconomics - Open, 2019, 3 : 177 - 188
  • [10] Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
    Emond, Bruno
    Joshi, Kruti
    El Khoury, Antoine C.
    Lafeuille, Marie-Helene
    Pilon, Dominic
    Tandon, Neeta
    Romdhani, Hela
    Lefebvre, Patrick
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 177 - 188
12345